Published in Endocr Relat Cancer on May 05, 2015
Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population. Medicine (Baltimore) (2016) 0.90
The role of LncRNA H19 in gender disparity of cholestatic liver injury in Mdr2(-/-) mice. Hepatology (2017) 0.81
LINC00978 predicts poor prognosis in breast cancer patients. Sci Rep (2016) 0.76
BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions. Oncotarget (2016) 0.75
Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication. Oncotarget (2016) 0.75
Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population. Onco Targets Ther (2017) 0.75
High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol (1987) 43.61
Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell (1977) 18.95
Genome-wide analysis of estrogen receptor binding sites. Nat Genet (2006) 18.63
Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell (2000) 11.10
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature (2012) 5.84
Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation (1998) 5.43
Progesterone induces adult mammary stem cell expansion. Nature (2010) 4.69
ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods (2009) 4.69
Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell (2003) 4.67
Estrogen and the risk of breast cancer. N Engl J Med (2001) 4.39
Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res (1997) 4.22
Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell (2008) 3.87
A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med (2008) 3.64
Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci U S A (2006) 3.32
Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci U S A (1984) 3.25
Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem (2001) 3.24
The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA (2007) 2.91
The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol (2012) 2.73
Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol (1999) 2.52
The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res (2006) 2.50
Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci U S A (2010) 2.46
The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development (1991) 2.17
Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol (2013) 2.07
Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia (1997) 2.04
H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem (2005) 2.04
Mammary stem cells and the differentiation hierarchy: current status and perspectives. Genes Dev (2014) 1.86
The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles. Cancer Res (2003) 1.81
Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes. Proc Natl Acad Sci U S A (1984) 1.80
Induction of mammary gland development in estrogen receptor-alpha knockout mice. Endocrinology (2000) 1.75
Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis (2002) 1.69
Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res (1987) 1.59
Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia (1998) 1.52
Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology (2000) 1.50
Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J Biol Chem (1988) 1.43
Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective. Stem Cell Rev (2007) 1.38
Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res (1994) 1.34
Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer. Breast Cancer Res (2005) 1.23
H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression. Am J Pathol (1998) 1.19
The product of the imprinted H19 gene is an oncofetal RNA. Mol Pathol (1997) 1.15
Influence of evolution in tumor biobanking on the interpretation of translational research. Cancer Epidemiol Biomarkers Prev (2008) 1.15
Steroid receptors in human breast cancer. Trends Endocrinol Metab (2004) 1.12
Estrogen receptor-alpha phosphorylated at Ser118 is present at the promoters of estrogen-regulated genes and is not altered due to HER-2 overexpression. Cancer Res (2006) 1.05
The NCIC-Manitoba Breast Tumor Bank: a resource for applied cancer research. CMAJ (1996) 1.05
Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells. J Mol Endocrinol (2005) 1.04
Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol (1997) 1.03
Steroid hormones modulate H19 gene expression in both mammary gland and uterus. Oncogene (1999) 1.03
Steroid receptors in human breast tumorigenesis and breast cancer progression. Biomed Pharmacother (2002) 1.02
Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium. Breast Cancer Res (2014) 0.97
Nkx3-1 and LEF-1 function as transcriptional inhibitors of estrogen receptor activity. Cancer Res (2008) 0.96
In vitro model systems for the study of hormone-dependent human breast cancer. N Engl J Med (1977) 0.96
Quantitation of human mammary epithelial stem cells with in vivo regenerative properties using a subrenal capsule xenotransplantation assay. Nat Protoc (2010) 0.91
The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas. Biol Cell (1995) 0.91
Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. Mol Cell Endocrinol (2012) 0.91
Cross-talk between mesenchyme and epithelium increases H19 gene expression during scattering and morphogenesis of epithelial cells. Exp Cell Res (2002) 0.88
Progesterone stimulates progenitor cells in normal human breast and breast cancer cells. Breast Cancer Res Treat (2014) 0.82
In vitro methods to culture primary human breast epithelial cells. Methods Mol Biol (2013) 0.80
Expression of the human fetal bac h19 gene in invasive cancers. Int J Oncol (1993) 0.80
Estrogen receptor residues required for stereospecific ligand recognition and activation. Mol Endocrinol (1997) 0.77